Evidence map›Paper›PMID 35860145›Full record

ArticleAnnals of medicine and surgery (2012)2022

Sarcomatoid carcinoma of the stomach: A very rare and extremely aggressive tumor; a case report.

Mohamed Amine Elghali, Mehdi Ben Abdelkrim, Soumaya Mrabet, Emna Aloui, Amal Letaief, Marwa Krifa, Mohamed Hedi Mraidha, Imtinene Belaid

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Annals of medicine and surgery (2012), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Mohamed Amine ElghaliDepartment of Surgery, Farhat Hached University Hopistal, Sousse, Tunisia.
Mehdi Ben AbdelkrimDepartment of Surgery, Farhat Hached University Hopistal, Sousse, Tunisia.
Soumaya MrabetDepartment of Gastro-enetrology, Farhat Hached University Hopistal, Sousse, Tunisia.
Emna AlouiDepartment of Surgery, Farhat Hached University Hopistal, Sousse, Tunisia.
Amal LetaiefDepartment of Surgery, Farhat Hached University Hopistal, Sousse, Tunisia.
Marwa KrifaDepartment of Pathology, Farhat Hached University Hopistal, Sousse, Tunisia.
Mohamed Hedi MraidhaDepartment of Surgery, Farhat Hached University Hopistal, Sousse, Tunisia.
Imtinene BelaidDepartment of Oncology Farhat Hached University Hopistal, Sousse, Tunisia.
Hôpital Farhat Hached · TN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Sarcomatoid carcinoma of the stomach is a very rare type of malignant gastric tumor characterized by distinct cell morphology.Only six cases have been reported in the literature. We report a case which illustrates the great rapidity of evolution and the aggressiveness of this histological type. Case presentation: A 80-year-old patient was explored for loss of 20 kg and epigastralgia. The explorations showed a non-metastatic antral sarcomatoid carcinoma with celiac necrotic lymphe node. The oncologic comitee decision was surgery straight away without perioperative chemotherapy.4 weeks after his first CT scan the patient was admitted for preparation for surgery. Clinical and morphological examination showed a clear increase in tumor size with associated tumor infection.The patient had distal gastrectomy. The tumor was perforated and locally advanced.The final pathological exams confirmed the histological type. Surgery was R0, but 4 months after surgery, local recurrence compressing gastro intestinal anastomosis was occurred. Clinical discussion: Operative difficulties and rapid recurrence after surgery would have been avoided by faster surgery after diagnosis. However, the surgery time was only 1 month, which illustrates the rapid evolution of sarcomatoid tumors. Conclusion: Sarcomatoid carcinoma is a rare tumor. These tumors can be aggressive with a large tumoral voulume and high rate of locoregional lymph node involvement. Our case illustrate the aggressiveness of this tumor. The benefit of peri-operative treatment is unknown.

Indexed as

Case reportEvolutionGastric cancerSarcomatoid carcinoma

Identifiers

PMID35860145
PMCPMC9289405
OpenAlexW4283027117

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.